Primary Cutaneous B-Cell Lymphomas

Area of Science:

• Dermatology
• Hematology
• Oncology

Background:

• Cutaneous B-cell lymphomas (B-CL) are often secondary to systemic disease.
• Primary cutaneous B-cell lymphomas (PC-BCL) are typically indolent, except for primary cutaneous diffuse large B-cell lymphoma-leg type (PCDLBCL-LT).
• Distinguishing indolent PC-BCL from cutaneous lymphoid hyperplasia (CLH) can be challenging.

Purpose of the Study:

• To review diagnostic approaches for specific PC-BCL subtypes.
• To highlight the differential diagnosis of PC-BCL.
• To emphasize the importance of clinical context in diagnosis.

Main Methods:

• Review of diagnostic strategies for primary cutaneous marginal zone lymphoma.
• Review of diagnostic strategies for primary cutaneous follicle center lymphoma.
• Review of diagnostic strategies for PCDLBCL-LT.

Main Results:

• Diagnostic challenges exist, particularly in differentiating indolent PC-BCL from CLH.
• PCDLBCL-LT represents an aggressive subtype requiring distinct diagnostic considerations.
• Integration of clinical, histological, and potentially molecular data is essential.

Conclusions:

• Accurate diagnosis of PC-BCL relies on a comprehensive approach.
• Understanding the specific subtypes and their clinical behavior is crucial.
• Differential diagnosis requires careful evaluation to guide appropriate management.